Skip To Main Content
Yinjun Lou on Muck Rack

Yinjun Lou

As seen in: Nature, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinjun

Contact Yinjun, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

|
By Chenying Li, Hongyan Tong, Huafeng Wang, Yanling Ren, Jiejing Qian, Xinping Zhou, Gaixiang Xu, Liangshun You, Liping Mao, Haitao Meng, Wenjuan Yu, Xingnong Ye, Min Yang, Jian Huang, De Zhou, Wanzhuo Xie, Jie Jin, Yinjun Lou
| Nature Verified
To the Editor: Philadelphia chromosome–positive (Ph⁺) acute lymphoblastic leukemia (ALL) accounts for approximately 20–30% of adult B-cell ALL cases [1]. Historically, Ph⁺ ALL has been associated with poor outcomes due to intrinsic chemoresistance. The integration of BCR::ABL1 tyrosine kinase inhibitors (TKIs) into frontline induction regimens has dramatically improved complete remission (CR) rates to >95%.
Open in Who Shared Issue with article?

Efficacy and safety of short-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia

|
By Ge Liu, Yile Zhou, Yinjun Lou, Liping Mao, Qian Wang, Hongfei Wu, Hongyan Tong, Xudong Wei, Jie Jin, Huafeng Wang, Qingsong Yin
| Nature Verified
To the Editor Blinatumomab has significantly improved survival in patients with relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) [1,2,3], particularly those with measurable residual disease (MRD) positivity [4]. Recently, it has been integrated into first-line therapy of B-ALL patients [5,6,7].
Open in Who Shared Issue with article?

Clinical characteristics of acute myeloid leukaemia patients with a large number of azurophilic granules: A single‐centre retrospective study

|
By Shuqi Zhao, Jinghan Wang, Xin Huang, Yinjun Lou
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interests. Supporting Information Filename Description bjh19494-sup-0001-TableS1.docxWord 2007 document , 14.8 KB Table S1. REFERENCES 1, , , . Proteome profiling of human neutrophil granule subsets, secretory vesicles, and cell membrane: correlation with transcriptome profiling of neutrophil precursors. J Leukoc Biol. 2013; 94(4): 711–721. 2, , , , , , et al.
Open in Who Shared Issue with article?
See all 3 articles